Blog

Happy Thanksgiving from BaseCase!

On behalf of the BaseCase team, I would like to wish everyone a very happy Thanksgiving holiday! While the NYC office will be closed during the holiday, our HQ in Berlin will be open for business as usual on Thursday and Friday.

Using RWD Tip #6 — Keep it simple and transparent

To present a credible value story, it’s essential to maintain transparency. If you’re using large datasets and novel sources of evidence, it’s even more important to offer clients easy access to your sources. When integrating real-world data into customer-facing tools, be sure to show, share and reference new da...

Dodgy Wi-Fi? Make sure your digital tools work offline

Traditionally, access to dynamic information such as real-world datasets has been provided via a central data repository referenced over the internet. However, it’s not always possible to guarantee a reliable internet connection in the field. Securing a meeting with an important payer or healthcare provider only to find that yo...

Using RWD: Tip #5 — Get a better MLR approval process

Market access professionals know all too well that the medical, legal and regulatory review process can be challenging to manage, and time-consuming to execute. However, with a modern MLR approval process it’s possible to use large real-world datasets in your customer engagement tools without causing extra delay. Part of th...

Localize real-world data to boost customer engagement

Real-world data is powerful partly because it can help communicate the potential impact of a new drug or medical device, not just in trials, but in the ‘real world’. But it’s important to appreciate how much ‘real world’ settings can differ between markets, products and regions - there is no single ...

What kinds of RWD can you use in a customer engagement tool?

Clever use of real-world data does not require supercomputers to crunch ‘big data’. We recommend identifying data sources early - perhaps as an extension of building a value dossier - and then incorporating that data into field-based applications. Useful sources to consider include: patient population data, prescribing information, pricing information, regi...

Get easy-to-update digital tools that integrate RWD

The market access landscape is constantly changing, and real-world data starts going out-of-date the moment it’s published. For it to deliver a meaningful edge in the field, RWD must be incorporated into your digital tools rapidly. One thing we learned in our discussions with clients and industry experts is th...

Avoid compliance problems using RWD in the field

Compliance is already the one thing most likely to keep market access professionals awake at night. As large real-world datasets start to become more important, the challenges of keeping on top of the evidence and staying compliant threaten to undermine sleep even further. Fortunately, there is a way to streamline ...

How to use real-world data to monitor competitive threats

In a dynamic and highly competitive market, two things are important: monitoring trends effectively, and having the capability to react fast. Real-world data can provide actionable insights into market developments. Commercial managers can use RWD to update internal audiences on market share, competitive threats from new efficacy data, or pricing ...

Can you afford not to use RWD in your tools?

At a time of rising costs, the thought of integrating large datasets into your customer engagement tools can seem daunting - but it needn’t be expensive, or time-consuming. ‘Big data’ is now used across the life science industries, for a range of purposes. It’s used to develop new drugs an...

BaseCase Berlin HQ to double in size

It’s been two years since BaseCase moved to a new and much larger HQ, close to the historic Checkpoint Charlie in Berlin. In that time we’ve continued to experience tremendous growth, with constantly increasing levels of interest in our customer engagement technology from clients in the areas of mark...

Happy 4th of July from BaseCase USA

The BaseCase USA team would like to wish all of our clients in the U.S. a happy 4th of July. We hope you enjoy the holiday! Please note that while the BaseCase office in New York is closed as our team celebrate the holiday, our HQ in Berlin is ...

Pfizer drops $160b Allergan deal

Pfizer has walked away from its record-breaking $160 billion deal with Allergan. The decision comes just days after action from the US Treasury to make such tax-inversion deals less attractive, a move widely believed to have been taken in direct response to the pharma giant’s headline-grabbing announcement. Under the planned ch...

$1.8b Novo Nordisk facility sign of growing diabetes market

Novo Nordisk has announced it will spend $1.8 billion on a new facility to produce active pharmaceutical ingredients (APIs) for its current and future insulin and GLP-1 medicines. The plant will cover an area the size of seven football pitches, and will be built next to an existing site, roughly half ...

'Brexit' spells years of chaos for UK pharma industry

Calling for an in-out referendum on the UK’s EU membership, Prime Minister David Cameron spoke of a ‘…crisis of European competitiveness, as other nations across the world soar ahead’. He also described ‘excessive regulation’ on business as a ‘self-inflicted wound’. Now, as the UK contemplates so-called Brexit, pharma and medical device...

Pfizer buys Allergan for $160 billion

The biggest pharmaceuticals deal in history is set to go ahead, as Pfizer announces the completion of its much-anticipated $160 billion agreement with Dublin-based Allergan Plc. Pfizer CEO Ian Read, who will become chief executive and chairman of the new business, commented that: The proposed combination of Pfizer and Allergan will ...

Happy Thanksgiving from BaseCase USA!

The BaseCase USA team would like to wish all of our clients in the U.S., and around the world, a happy Thanksgiving. We hope you enjoy the holiday! Please note that while the BaseCase office in New York will be closed as our team celebrate the holiday, our HQ ...

New diagnostic techniques promise better cancer treatment

A medium-sized revolution is underway in the tumor profiling market, propelling point-of-care diagnostics, cost-effective treatment options, and personalized medicine to the fore. The implications for the major medical device and diagnostics players are considerable. As the below graph indicates, the value of this market is expected to increase from $13 billion ...

Pharma outlook: pricing and market access

We’ve remarked previously that the general outlook for the life sciences industry in the coming period is positive, and the below forecast from a Deloitte report supports that view. This outlook is based partly on the observation that: “…improving R&D productivity, recent increases in NME approvals, and expa...